Financial reports
10-Q
2024 Q1
Quarterly report
10 May 24
ARS
2023 FY
Annual report to shareholders
1 May 24
10-K/A
2023 FY
Annual report (amended)
24 Apr 24
10-K
2023 FY
Annual report
15 Mar 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
15 Mar 23
Current reports
8-K
Submission of Matters to a Vote of Security Holders
20 Jun 24
8-K
XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus
4 Jan 24
8-K
Submission of Matters to a Vote of Security Holders
23 Jun 23
8-K
Departure of Directors or Certain Officers
14 Feb 23
8-K
Submission of Matters to a Vote of Security Holders
29 Jun 22
8-K
Changes in Registrant's Certifying Accountant
13 May 22
8-K
Entry into a Material Definitive Agreement
2 Feb 22
8-K
XBiotech Announces Dividend to Holders of Common Stock
6 Jul 21
8-K
Submission of Matters to a Vote of Security Holders
29 Jun 20
8-K
XBiotech Closes on Sale of True Human Antibody Bermekimab to Janssen
30 Dec 19
Registration and prospectus
SC TO-I/A
Issuer tender offer statement (amended)
20 Jun 23
SC TO-I
Issuer tender offer statement
17 May 23
S-8
Registration of securities for employees
2 Oct 20
SC TO-I/A
Issuer tender offer statement (amended)
19 Feb 20
SC TO-I/A
Issuer tender offer statement (amended)
13 Feb 20
SC TO-I/A
Issuer tender offer statement (amended)
13 Feb 20
SC TO-I/A
Issuer tender offer statement (amended)
5 Feb 20
SC TO-I
Issuer tender offer statement
14 Jan 20
424B5
Prospectus supplement for primary offering
3 Jun 19
S-3MEF
Registration of additional securities for an S-3
31 May 19
Proxies
DEFA14A
Additional proxy soliciting materials
1 May 24
DEF 14A
Definitive proxy
1 May 24
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
DEFA14A
Additional proxy soliciting materials
13 May 22
DEF 14A
Definitive proxy
13 May 22
DEFA14A
Additional proxy soliciting materials
29 Apr 21
DEF 14A
Definitive proxy
29 Apr 21
DEFA14A
Additional proxy soliciting materials
29 Apr 20
DEF 14A
Definitive proxy
29 Apr 20
Other
UPLOAD
Letter from SEC
1 Oct 18
CORRESP
Correspondence with SEC
4 Sep 18
UPLOAD
Letter from SEC
6 Aug 18
CORRESP
Correspondence with SEC
31 Jul 18
UPLOAD
Letter from SEC
24 Jul 18
EFFECT
Notice of effectiveness
1 Sep 16
CORRESP
Correspondence with SEC
30 Aug 16
UPLOAD
Letter from SEC
26 Aug 16
CT ORDER
Confidential treatment order
15 Apr 15
EFFECT
Notice of effectiveness
14 Apr 15